R Krech Selected Research

Chemoradiotherapy

6/2001

[The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Krech Research Topics

Disease

2	Neoplasms (Cancer) 12/2015 - 02/2000
2	Breast Neoplasms (Breast Cancer) 12/2015 - 01/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 06/2001 - 02/2000
1	Squamous Cell Carcinoma of Head and Neck 06/2001
1	Hyperplasia 09/2000
1	Carcinoma (Carcinomatosis) 09/2000

Drug/Important Bio-Agent (IBA)

2	Phenobarbital (Luminal)FDA Link 12/2015 - 09/2000
2	Cisplatin (Platino)FDA LinkGeneric 06/2001 - 02/2000
2	Ifosfamide FDA LinkGeneric 06/2001 - 02/2000
1	TensinsIBA 12/2015
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 12/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Mesna (Coenzyme M)FDA LinkGeneric 06/2001
1	Keratin-5 (Keratin 5)IBA 09/2000
1	Hemoglobins (Hemoglobin)IBA 02/2000

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 06/2001 - 02/2000
1	Chemoradiotherapy 06/2001
1	Neck Dissection (Radical Neck Dissection) 02/2000
1	Induction Chemotherapy 02/2000
1	Radiotherapy 02/2000
1	Therapeutics 02/2000